FDA Greenlights Updated COVID Vaccines for Vulnerable Populations
Published on: Aug. 27, 2025, 11:07 p.m. | Source: Devdiscourse
The FDA has approved updated COVID-19 vaccines for people aged 65 and older, and those under 65 with higher health risks. Manufactured by Pfizer/BioNTech, Moderna, and Novavax, these vaccines target vulnerable populations. Pfizer's vaccine for children under 5 has been rescinded, while Moderna's is now approved for ages six months and up.
